Potential Neuropathic Pain Treatment Shows Promise in Preclinical Tests, Newsroom

A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study.

Full article: Sensing Evoked Compound Action Potentials from the

Parasympathetic Nervous System and Heart Failure

Potential Neuropathic Pain Treatment Shows Promise in Preclinical

Artificial intelligence and machine learning in clinical

Akelos

Targeting nociceptive transient receptor potential channels to

Can Psychedelic Drugs Treat Physical Pain?

First-in-Human Experience and Acute Procedural Outcomes Using a

Current Clinical Applications of In Vivo Gene Therapy with AAVs

Dr. Peter Goldstein

CMT1A Ionis Press Release Charcot–Marie–Tooth Association

Sea urchins: an update on their pharmacological properties [PeerJ]

Therapeutic potential of conopeptides

2022 - Pain Practice - Wiley Online Library